CIPO Patents = 1

EPO Patents = 1

Trademarks = 5

Forward Citations = 8

Loading Chart...

2 inventors (with patents filed for the assignee):

Simon Beaudoin (8 out of 9 patents)

Jeffrey Victor Leyton (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12350346 - Conjugates enhancing total cellular accumulation (2025-07-08),

2. 12233130 - Covalently-modified steroid acid-peptides having enhanced stability and/or biological activity (2025-02-25),

3. 12150989 - Covalently modified antigens for improved immune response and/or stability (2024-11-26),

4. 12076396 - Steroid acid-based immunogen enhancers (2024-09-03),

5. 11890350 - Steroid acid-peptide based cytotoxic compounds (2024-02-06),

6. 11612651 - Steroid acid-based immunogen enhancers (2023-03-28),

7. 11352437 - Conjugates enhancing total cellular accumulation (2022-06-07),

8. 11291717 - Covalently modified antigens for improved immune response and/or stability (2022-04-05),

Company Overview

Defence Therapeutics Inc. is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases. Their proprietary technology platform allows for the rapid design and development of innovative drug candidates with enhanced efficacy and safety profiles. With a strong pipeline of potential therapies, Defence Therapeutics is poised to make a significant impact in the field of biotechnology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#121 in Vancouver

#1,878 in Canada

Vancouver, Canada

Defence Therapeutics Inc.

Forward Citations = 8

2 inventors:

Simon Beaudoin (8 out of 9 patents)

Jeffrey Victor Leyton (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Defence Therapeutics Inc.. Retrieved from https://idiyas.com/company/defence-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]